The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the industry. A shift away from Schedule I status, often regarded as outdated and hindering https://tiffanyjwbw446751.wikicorrespondent.com/6854520/cannabinoid_rescheduling_a_development_catalyst